Urgent Meds

Tabrecta (Capmatinib)

  • Medicine Name: Tabrecta
  • Generic Name: Capmatinib
  • Dosage Form & Strength: Tablets: 150/200 mg
  • Manufactured By: Novartis Pharma Corporation

Tabrecta is a kinase inhibitor used for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to MET (Mesenchymal-Epithelial Transition) exon-14 skipping.

Recommended Dosage: The recommended dosage is 400 mg orally twice daily with or without food. Swallow the tablets of Tabrecta whole, without breaking, crushing or chewing. In case a patient misses or vomits any dose, instruct the patient not to make up the dose, but to take the very next dose at its scheduled time.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.